The CDC’s elevated measles case curve — including two counted U.S. deaths and the highest caseload in about 35 years — remains Thursday’s lead public-health carry after Washington Post and Al Jazeera reporting late September. Clinicians still emphasize two MMR doses for eligible children and catch-up for adults without documented immunity.

Backstory: under-vaccinated communities drove 2026 clusters. Watch CDC’s weekly update page. Agree cases are historically high; differ on how states should enforce school exclusion.

As of Thursday, October 1, the public record on “CDC measles tally still at a 35-year case high” still matches the facts above. Health coverage stays practical: what agencies advise, what patients can do, and where doctors still disagree. Reporting from The Washington Post, Al Jazeera, CDC anchors the Sources list; this card does not invent tallies, quotes, or outcomes beyond what those links support.

For a reader new to the thread: Two U.S. measles deaths remain on the federal ledger. School-year catch-up shots are still the clinical advice. Readers can follow the linked Sources for the latest confirmed detail on Thursday. A short history beat matters here — prior seasons, rulings, product cycles, or diplomatic rounds set up today’s stakes — so the same-day news sits in context without filler. When the story is still moving, the copy states what is locked and what remains unsettled.

Where coverage lines up, Washington Post, Al Jazeera, and CDC materials agree the U.S. faces a historically high measles caseload with two counted deaths. Where accounts still diverge, Public-health officials push MMR catch-up; vaccine skeptics dispute risk framing. Putting the shared facts and the plain-language split side by side lets readers judge the next development for themselves.